Related Experiment Video
Updated: Feb 14, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients
Dragana Lovre1, Sulay Shah2, Aanu Sihota2
1Section of Endocrinology, Tulane University Health Sciences Center, 1430 Tulane Avenue, #8553, New Orleans, LA 70112, USA; Section of Endocrinology, Southeast Louisiana Veterans Health Care Systems, 2400 Canal Street, New Orleans, LA 70119, USA.
Insights
Patients with chronic kidney disease (CKD) face higher cardiovascular disease (CVD) risks. Managing glucose and lipid levels is key to reducing cardiovascular events and microvascular complications in CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Chronic kidney disease (CKD) is strongly associated with increased cardiovascular disease (CVD) risk.
- Understanding the mechanisms linking CKD and CVD is crucial for effective patient management.
- Microvascular complications are a significant concern in CKD patients.
Purpose of the Study:
- To review the mechanisms underlying elevated CVD risk in CKD patients.
- To discuss strategies for managing cardiovascular (CV) risk in this population.
- To highlight the importance of glycemic and lipid control in mitigating CV events and microvascular disease progression.
Main Methods:
- Comprehensive literature search of PubMed without date limitations.
- In-depth discussion and consensus among all authors.
- Reference chaining of selected pertinent articles to identify additional relevant publications.
Main Results:
- Identified key mechanisms contributing to increased CVD in CKD.
- Emphasized the role of glucose and lipid reduction in managing CV risk.
- Highlighted strategies focused on decreasing CV events and microvascular complications.
Conclusions:
- Effective management of CKD-associated CVD requires a multifaceted approach.
- Controlling glucose and lipid levels are primary targets for reducing cardiovascular and microvascular complications.
- Further research and clinical strategies should focus on these key modifiable risk factors.
Abstract:
We discuss mechanisms of increased cardiovascular disease (CVD) in patients with chronic kidney disease (CKD) and strategies for managing cardiovascular (CV) risk in these patients. Our focus was mainly on decreasing CV events and progression of microvascular complications by reducing levels of glucose and lipids. We searched PubMed with no limit on the date of the article. All articles were discussed among all authors. We chose pertinent articles, and searched their references in turn for additional relevant publications.
More Related Videos
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Kidney Disease III: Interprofessional Care
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

